Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): A randomised, phase 3 trial

on behalf of the Pasireotide C2402 Study Group

Research output: Contribution to journal › Article › peer-review

298 Scopus citations

Fingerprint

Dive into the research topics of 'Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): A randomised, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences